ESPP purchase adds shares for Intensity Therapeutics (NASDAQ: INTS) officer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
INTENSITY THERAPEUTICS, INC. Principal Accounting Officer John M. Wesolowski acquired 3,688 shares of common stock on an exempt basis through the company’s Amended and Restated 2024 Employee Stock Purchase Plan. The shares were purchased at $3.485 each, bringing his direct holdings to 7,102 shares.
Under the plan, the purchase price equaled 85% of the closing price of the common stock on June 30, 2026. All share amounts reported reflect a 1-for-25 reverse split of the company’s common stock that became effective on February 18, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Wesolowski John M
Role
Principal Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.0001 Par Value | 3,688 | $3.485 | $13K |
Holdings After Transaction:
Common Stock, $0.0001 Par Value — 7,102 shares (Direct, null)
Footnotes (1)
- The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's Amended and Restated 2024 Employee Stock Purchase Plan (ESPP) in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2026. On February 18, 2026, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split.
Key Figures
Shares acquired: 3,688 shares
Purchase price: $3.485 per share
Holdings after transaction: 7,102 shares
+1 more
4 metrics
Shares acquired
3,688 shares
Common stock acquired through 2024 ESPP on June 30, 2026
Purchase price
$3.485 per share
ESPP purchase price equal to 85% of June 30, 2026 close
Holdings after transaction
7,102 shares
Direct ownership after ESPP acquisition, post-split
Reverse split ratio
1-for-25
Common stock reverse split effective February 18, 2026
Key Terms
Amended and Restated 2024 Employee Stock Purchase Plan, Rule 16b-3(c), Rule 16b-3(d), reverse split, +1 more
5 terms
Amended and Restated 2024 Employee Stock Purchase Plan financial
"the acquisition of shares under the Issuer's Amended and Restated 2024 Employee Stock Purchase Plan (ESPP)"
Rule 16b-3(c) regulatory
"in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
Rule 16b-3(d) regulatory
"in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
reverse split financial
"the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock"
A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.
Principal Accounting Officer financial
"Wesolowski John M, Principal Accounting Officer"
The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.
FAQ
What insider transaction did Intensity Therapeutics (INTS) report for John M. Wesolowski?
Intensity Therapeutics reported that Principal Accounting Officer John M. Wesolowski acquired 3,688 shares of common stock through the company’s 2024 Employee Stock Purchase Plan. This exempt, plan-based acquisition increased his direct ownership to 7,102 shares after the transaction, reflecting participation in the employee equity program.
Is the Intensity Therapeutics (INTS) Form 4 transaction an open-market trade?
No. The transaction reflects shares acquired under the Amended and Restated 2024 Employee Stock Purchase Plan in an exempt transaction. The filing specifies that the acquisition is exempt under Rule 16b-3(c) and Rule 16b-3(d), distinguishing it from open-market buying or selling activity.